Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Signal transduction by receptors with tyrosine kinase activity
Ullrich, A., & Schlessinger, J. (1990) · Cell · doi:10.1016/0092-8674(90)90801-k · Cited by 5,435
Shiang, R., Thompson, L. M., Zhu, Y.-Z., Church, D. M., Fielder, T. J., Bocian, M., Winokur, S. T., & Wasmuth, J. J. (1994) · Cell · doi:10.1016/0092-8674(94)90302-6 · Cited by 1,329
Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome
Wilkie, A. O. M., Slaney, S. F., Oldridge, M., Poole, M. D., Ashworth, G. J., Hockley, A. D., Hayward, R. D., David, D. J., Pulleyn, L. J., Rutland, P., et al. (1995) · Nature Genetics · doi:10.1038/ng0295-165 · Cited by 935
Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia
Rousseau, F., Bonaventure, J., Legeai-Mallet, L., Pelet, A., Rozet, J.-M., Maroteaux, P., Merrer, M. L., & Munnich, A. (1994) · Nature · doi:10.1038/371252a0 · Cited by 928
Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome
Reardon, W., Winter, R. M., Rutland, P., Pulleyn, L. J., Jones, B. M., & Malcolm, S. (1994) · Nature Genetics · doi:10.1038/ng0994-98 · Cited by 758
A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome
Muenke, M., Schell, U., Hehr, A., Robin, N. H., Losken, H. W., Schinzel, A., Pulleyn, L. J., Rutland, P., Reardon, W., Malcolm, S., et al. (1994) · Nature Genetics · doi:10.1038/ng1194-269 · Cited by 614
Tavormina, P. L., Shiang, R., Thompson, L. M., Zhu, Y.-Z., Wilkin, D. J., Lachman, R. S., Wilcox, W. R., Rimoin, D. L., Cohn, D. H., & Wasmuth, J. J. (1995) · Nature Genetics · doi:10.1038/ng0395-321 · Cited by 601
FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern.
Partanen, J., Mäkelä, T. P., Eerola, E., Korhonen, J., Hirvonen, H., Claesson-Welsh, L., & Alitalo, K. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07654.x · Cited by 533
Achondroplasia is defined by recurrent G380R mutations of FGFR3.
Bellus, G. A., Hefferon, T. W., Luna, R. I. O. D., Hecht, J. T., Horton, W. A., Machado, M. A., Kaitila, I., McIntosh, I., & Francomano, C. A. (1995) · PubMed Central · Cited by 530
Bellus, G. A., McIntosh, I., Smith, E. A., Aylsworth, A. S., Kaitila, I., Horton, W. A., Greenhaw, G. A., Hecht, J. T., & Francomano, C. A. (1995) · Nature Genetics · doi:10.1038/ng0795-357 · Cited by 473
Cited by
The Fibroblast Growth Factor signaling pathway
Ornitz, D. M., & Itoh, N. (2015) · WIREs Developmental Biology · doi:10.1002/wdev.176 · Cited by 2,050
Biological Roles of Fibroblast Growth Factor-2*
Bikfalvi, A., Klein, S., Pintucci, G., & Rifkin, D. B. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0292 · Cited by 959
Ornitz, D. M., & Marie, P. J. (2002) · Genes & Development · doi:10.1101/gad.990702 · Cited by 905
Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3
Colvin, J. S., Bohne, B. A., Harding, G. W., McEwen, D. G., & Ornitz, D. M. (1996) · Nature Genetics · doi:10.1038/ng0496-390 · Cited by 873
Olsen, B. R., Reginato, A. M., & Wang, W. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.191 · Cited by 822
Multiple Myeloma: Increasing Evidence for a Multistep Transformation Process
Hallek, M., Leif Bergsagel, P., & Anderson, K. C. (1998) · Blood · doi:10.1182/blood.v91.1.3 · Cited by 752
Mutations in TWIST, a basic helix–loop–helix transcription factor, in Saethre-Chotzen syndrome
Howard, T. D., Paznekas, W. A., Green, E. D., Chiang, L. C., Ma, N., Luna, R. I. O. D., Delgado, C. G., Gonzalez-Ramos, M., Kline, A. D., & Jabs, E. W. (1997) · Nature Genetics · doi:10.1038/ng0197-36 · Cited by 653
Self-citationFibroblast growth factors and their receptors in cancer
Wesche, J., Haglund, K., & Haugsten, E. M. (2011) · Biochemical Journal · doi:10.1042/bj20101603 · Cited by 534
Craniosynostosis: genes and mechanisms
Wilkie, A. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.10.1647 · Cited by 529
Achondroplasia: a comprehensive clinical review
Pauli, R. M. (2019) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-018-0972-6 · Cited by 491
Kinase mutations in human disease: interpreting genotype–phenotype relationships
Lahiry, P., Torkamani, A., Schork, N. J., & Hegele, R. A. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2707 · Cited by 420
Management of craniosynostoses
Renier, D., Lajeunie, E., Arnaud, E., & Marchac, D. (2000) · Child s Nervous System · doi:10.1007/s003810000320 · Cited by 384
FGF signaling in the developing endochondral skeleton
Ornitz, D. M. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.02.003 · Cited by 356
Vajo, Z., Francomano, C. A., & Wilkin, D. J. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0387 · Cited by 350
Exclusive paternal origin of new mutations in Apert syndrome
Moloney, D. M., Slaney, S. R., Oldridge, M., Wall, S. A., Sahlin, P., Stenman, G., & Wilkie, A. O. M. (1996) · Nature Genetics · doi:10.1038/ng0596-48 · Cited by 320
FGFR activation in skeletal disorders: Too much of a good thing
Webster, M. (1997) · Trends in Genetics · doi:10.1016/s0168-9525(97)01131-1 · Cited by 317
Bellus, G. A., Gaudenz, K., Zackai, E. H., Clarke, L. A., Szabo, J., Francomano, C. A., & Muenke, M. (1996) · Nature Genetics · doi:10.1038/ng1096-174 · Cited by 316
Clinical spectrum of fibroblast growth factor receptor mutations
Passos-Bueno, M. R., Wilcox, W. R., Jabs, E. W., Serti�, A. L., Alonso, L. G., & Kitoh, H. (1999) · Human Mutation · doi:10.1002/(sici)1098-1004(1999)14:2<115::aid-humu3>3.0.co;2-2 · Cited by 293
Self-citationA Genetic-Pathophysiological Framework for Craniosynostosis
Twigg, S. R. F., & Wilkie, A. O. M. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.07.006 · Cited by 276
Chiari malformation in craniosynostosis
Cinalli, G., Spennato, P., Sainte-Rose, C., Arnaud, E., Aliberti, F., Brunelle, F., Cianciulli, E., & Renier, D. (2005) · Child's Nervous System · doi:10.1007/s00381-004-1115-z · Cited by 273
Kan, S.-H., Elanko, N., Johnson, D., Cornejo-Roldan, L., Cook, J., Reich, E. W., Tomkins, S., Verloes, A., Twigg, S. R. F., Rannan-Eliya, S., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/338758 · Cited by 265
F ROM Z EBRAFISH TO H UMAN: Modular Medical Models
Shin, J. T., & Fishman, M. C. (2002) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.3.031402.131506 · Cited by 261
Achondroplasia: Development, pathogenesis, and therapy
Ornitz, D. M., & Legeai‐Mallet, L. (2017) · Developmental Dynamics · doi:10.1002/dvdy.24479 · Cited by 259
Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome
Yu, K., Herr, A. B., Waksman, G., & Ornitz, D. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14536 · Cited by 258
Role of Receptor Tyrosine Kinase Transmembrane Domains in Cell Signaling and Human Pathologies
Li, E., & Hristova, K. (2006) · Biochemistry · doi:10.1021/bi060609y · Cited by 258
Mechanism of FGF receptor dimerization and activation
Sarabipour, S., & Hristova, K. (2016) · Nature Communications · doi:10.1038/ncomms10262 · Cited by 255
Wilkie, A. O. M. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.03.001 · Cited by 255
Mathijssen, I. M. J. (2015) · Journal of Craniofacial Surgery · doi:10.1097/scs.0000000000002016 · Cited by 232
FGF signaling in skeletal development
Ornitz, D. M. (1998) · Frontiers in Bioscience · doi:10.2741/a321 · Cited by 215
Fibroblast growth factor receptor 2 mutations in Beare–Stevenson cutis gyrata syndrome
Przylepa, K. A., Paznekas, W., Zhang, M., Golabi, M., Bias, W., Bamshad, M. J., Carey, J. C., Hall, B. D., Stevenson, R., Orlow, S. J., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-492 · Cited by 185
Self-citationGenetic advances in craniosynostosis
Lattanzi, W., Barba, M., Di Pietro, L., & Boyadjiev, S. A. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38159 · Cited by 129
Martin, L., Kaci, N., Estibals, V., Goudin, N., Garfa-Traore, M., Benoist-Lasselin, C., Dambroise, E., & Legeai-Mallet, L. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddx374 · Cited by 51
“drome (9) and Crouzon syndrome associated with acanthosis nigricans is a rare syndrome (10).”
BackgroundClinical and genetic characteristics of craniosynostosis in Hungary
Bessenyei, B., Nagy, A., Szakszon, K., Mokánszki, A., Balogh, E., Ujfalusi, A., Tihanyi, M., Novák, L., Bognár, L., & Oláh, É. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37298 · Cited by 16
“Pro250Argmutation is associatedwithMuenke syndrome, whereas p.Ala391Glu in the same molecule results in Crouzon syndrome with acanthosis nigricans [Meyers et al., 1995; Muenke et al., 1997].”
Background
Metadata
- Authors
- Meyers, G. A., Orlow, S. J., Munro, I. R., Przylepa, K. A., & Jabs, E. W.
- Venue
- Nature Genetics
- Published
- 1995-12
- Volume
- 11
- Issue
- 4
- Pages
- 462-464
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2011421080
- Cited by
- 390
- References
- 26
- FWCI
- 13.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.